Maze Therapeutics is eyeing a $113 million initial public offering a little under two months after revealing a $115 million Series D.
The clinical-stage biotech …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
“Swiss research institute established to focus on immune engineering and advancing global child and adolescent health.”
A week after Hurricane Helene wreaked havoc across the Southeast, the storm’s impact on healthcare continues. Hospitals in states including Tennessee, North Carolina, Florida, and
Gamertsfelder is a clinical and policy researcher. Osipenko leads a non-profit dedicated to improving the quality and integrity of clinical research. I am greeted with